Log in to your Inderes Free account to see all free content on this page.
Lipigon Pharmaceuticals
0.125
SEK
+0.48 %
LPGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
+0.48%
+8.67%
-35.36%
-39.57%
-63.01%
-74.92%
-97.15%
-
-98.3%
Lipigon Pharmaceuticals operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and includes drugs for rare diseases. These are mainly treatments for diseases caused by disorders in the body's handling of fats. In addition to the main business, service and associated ancillary services are also offered. Lipigon Pharmaceuticals operates worldwide, with the largest presence in the Nordic market.
Read moreMarket cap
18.6M SEK
Turnover
11.09K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
19.2.
2025
Annual report '24
27.5.
2025
Interim report Q1'25
26.8.
2025
Interim report Q2'25
ShowingAll content types
Första patienten doserad i Lipigon Pharmaceuticals kliniska fas II-studie med Lipisense®
Lipigon's development partner Leaderna Therapeutics reports last person treated in ongoing Phase 1 study with Lipisense®
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio